Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.
Green, J R
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group. [electronic resource] - Alimentary pharmacology & therapeutics Dec 1998 - 1207-16 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0269-2813
10.1046/j.1365-2036.1998.00427.x doi
Adolescent
Adult
Aged
Aminosalicylic Acids--administration & dosage
Anti-Ulcer Agents--therapeutic use
Colitis, Ulcerative--drug therapy
Delayed-Action Preparations--pharmacokinetics
Double-Blind Method
Female
Headache--chemically induced
Humans
Male
Mesalamine--administration & dosage
Middle Aged
Phenylhydrazines
Secondary Prevention
Time Factors
Treatment Failure
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group. [electronic resource] - Alimentary pharmacology & therapeutics Dec 1998 - 1207-16 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0269-2813
10.1046/j.1365-2036.1998.00427.x doi
Adolescent
Adult
Aged
Aminosalicylic Acids--administration & dosage
Anti-Ulcer Agents--therapeutic use
Colitis, Ulcerative--drug therapy
Delayed-Action Preparations--pharmacokinetics
Double-Blind Method
Female
Headache--chemically induced
Humans
Male
Mesalamine--administration & dosage
Middle Aged
Phenylhydrazines
Secondary Prevention
Time Factors
Treatment Failure